NEUROQUEST
NeuroQuest is developing a simple diagnostic blood test for at-risk populations. The test will serve as a surrogate to costly PET scans indicating the possible formation of brain plaques in the pre-clinical stage . BACKGROUND: Worldwide, nearly 47 million people have Alzheimer’s or a related dementia. In the United States, 5.3 million people are living with Alzheimer’s. Unless a cure is found, that number will rise to 16 million by 2050. Alzheimer’s is primarily diagnosed only after outward symptoms appear. To date, no cost-effective, accurate and practical tool exists to enable early diagnosis and treatment in the pre-clinical stage of Alzheimer’s when testing and/or therapeutic intervention may yield the greatest benefit.
NEUROQUEST
Industry:
Biopharma Biotechnology Developer Tools Health Care
Founded:
2008-01-01
Address:
Misgav, HaZafon, Israel
Country:
Israel
Website Url:
http://www.neuro-quest.com
Total Employee:
1+
Status:
Active
Contact:
+972.72.260.7000
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Google Font API WordPress Sitelinks Search Box Yoast WordPress SEO Plugin Yoast SEO Premium Yoast Plugins Person Schema WordPress 6.0 Gravatar Profiles
Current Employees Featured
Founder
Investors List
South Carolina Research Authority
South Carolina Research Authority investment in Venture Round - NeuroQuest
